Bozkurt Babuş Seyran, Köse Ataman, Erdoğan Semra, Kiraz Mesut, İyikesici Fulya
Emergency Medicine Department, Faculty of Medicine, Mersin University, Mersin, Turkey.
Biostatistics and Medical Informatics Department, Faculty of Medicine, Mersin University Mersin, Mersin, Turkey.
Ir J Med Sci. 2023 Apr;192(2):861-870. doi: 10.1007/s11845-022-02989-w. Epub 2022 Apr 14.
This study was aimed at determining the risk factors associated with mortality in elderly patients with severe hyponatremia admitted to the emergency department.
The data of patients aged ≥ 65 years who were admitted to the emergency department and whose serum sodium levels were < 125 mEq/L were retrospectively collected.
Mortality was associated with chronic liver disease/cirrhosis (p = 0.036), metastatic tumor (p = 0.007) and solid tumor (p = 0.013) cancers, antiarrhythmic drug use (p = 0.003), potassium-sparing diuretic use (p = 0.044), antineoplastic drug use (p = 0.0029), and dialysis treatment (p = 0.015). The following cutoff values were determined to be predictive of mortality: urea > 63.6 (AUC: 0.771; p = 0.0001), creatinine > 1.39 (AUC: 0.675; p = 0.0003), potassium > 4.64 (AUC: 0.711; p = 0.0001), C-reactive protein > 44 (AUC: 0.765; p = 0.0001), white blood cell count > 12.21 (AUC: 0.688; p = 0.0001), hemoglobin < 11.2 (AUC: 0.611; p = 0.0103), and Charlson comorbidity index > 2 (AUC: 0.739; p = 0.0001). The use of antineoplastic drugs (OR: 4.502; p = 0.010) and increased values of the following were associated with an increased risk of mortality: urea (OR: 1.007; p = 0.024), C-reactive protein (OR: 1.005; p = 0.026), glucose (OR: 1.008; p = 0.001), and Charlson comorbidity index (OR: 1.198; p = 0.025).
Malignancy; liver cirrhosis; dialysis treatment; increased Charlson comorbidity index, urea, and C-reactive protein values and the use of antineoplastic drugs are associated with mortality.
本研究旨在确定急诊科收治的老年严重低钠血症患者的死亡相关危险因素。
回顾性收集年龄≥65岁、因血清钠水平<125 mEq/L而入住急诊科患者的数据。
死亡与慢性肝病/肝硬化(p = 0.036)、转移性肿瘤(p = 0.007)和实体肿瘤(p = 0.013)、使用抗心律失常药物(p = 0.003)、使用保钾利尿剂(p = 0.044)、使用抗肿瘤药物(p = 0.0029)以及透析治疗(p = 0.015)相关。确定以下临界值可预测死亡:尿素>63.6(曲线下面积:0.771;p = 0.0001)、肌酐>1.39(曲线下面积:0.675;p = 0.0003)、钾>4.64(曲线下面积:0.711;p = 0.0001)、C反应蛋白>44(曲线下面积:0.765;p = 0.0001)、白细胞计数>12.21(曲线下面积:0.688;p = 0.0001)、血红蛋白<11.2(曲线下面积:0.611;p = 0.0103)以及Charlson合并症指数>2(曲线下面积:0.739;p = 0.0001)。使用抗肿瘤药物(比值比:4.502;p = 0.010)以及以下指标升高与死亡风险增加相关:尿素(比值比:1.007;p = 0.024)、C反应蛋白(比值比:1.005;p = 0.026)、葡萄糖(比值比:1.008;p = 0.001)以及Charlson合并症指数(比值比:1.198;p = 0.025)。
恶性肿瘤、肝硬化、透析治疗、Charlson合并症指数、尿素和C反应蛋白值升高以及使用抗肿瘤药物与死亡相关。